Sex Steroid Hormones, Hormonal Contraception, and the Immunobiology of Human Immunodeficiency Virus-1 Infection

Overview

Journal Endocr Rev

Publisher Oxford University Press

Specialty Endocrinology

Date 2009 Nov 12

PMID 19903932

Citations 83

Authors

Zdenek Hel

Elizabeth Stringer

Jiri Mestecky

Affiliations

Soon will be listed here.

Abstract

Worldwide, an increasing number of women use oral or injectable hormonal contraceptives. However, inadequate information is available to aid women and health care professionals in weighing the potential risks of hormonal contraceptive use in individuals living with HIV-1 or at high risk of infection. Numerous epidemiological studies and challenge studies in a rhesus macaque model suggest that progesterone-based contraceptives increase the risk of HIV-1 infection in humans and simian immunodeficiency virus (SIV) infection in macaques, accelerate disease progression, and increase viral shedding in the genital tract. However, because several other studies in humans have not observed any effect of exogenously administered progesterone on HIV-1 acquisition and disease progression, the issue continues to be a topic of intense research and ongoing discussion. In contrast to progesterone, systemic or intravaginal treatment with estrogen efficiently protects female rhesus macaques against the transmission of SIV, likely by enhancing the natural protective properties of the lower genital tract mucosal tissue. Although the molecular and cellular mechanisms underlying the effect of sex steroid hormones on HIV-1 and SIV acquisition and disease progression are not well understood, progesterone and estrogen are known to regulate a number of immune mechanisms that may exert an effect on retroviral infection. This review summarizes current knowledge of the effects of various types of sex steroid hormones on immune processes involved in the biology of HIV-1 infection.

Citing Articles

NET-EN treatment leads to delayed HSV-2 infection, enhanced mucin and T cell functions in the female genital tract when compared to DMPA in a preclinical mouse model.

Mian M, Pa S, Rahman N, Gillgrass A, Kaushic C Front Immunol. 2024; 15:1427842.

PMID: 39569191 PMC: 11576457. DOI: 10.3389/fimmu.2024.1427842.

Sero-prevalence of syphilis and associated risk factors among pregnant women attending antenatal care at an urban-poor health centre in Kampala, Uganda: a cross-sectional study.

Simiyu A, Atuheire C, Taremwa M, Ssali S, Mwiine F, Kankya C Pan Afr Med J. 2024; 47:129.

PMID: 38854863 PMC: 11161699. DOI: 10.11604/pamj.2024.47.129.31622.

Contraception in Medically Complex Adolescents and Young Adults.

Addison J, Hassan A, DiVasta A Open Access J Contracept. 2024; 15:69-83.

PMID: 38812474 PMC: 11134286. DOI: 10.2147/OAJC.S424068.

Female Sex Hormones Upregulate the Replication Activity of HIV-1 Sub-Subtype A6 and CRF02_AG but Not HIV-1 Subtype B.

Nosik M, Berezhnya E, Bystritskaya E, Kiseleva I, Lobach O, Kireev D Pathogens. 2023; 12(7).

PMID: 37513727 PMC: 10383583. DOI: 10.3390/pathogens12070880.

Vitamin D and estrogen steroid hormones and their immunogenetic roles in Infectious respiratory (TB and COVID-19) diseases.

Eduarda de Albuquerque Borborema M, de Lucena T, de Azevedo Silva J Genet Mol Biol. 2023; 46(1 Suppl 2):e20220158.

PMID: 36745756 PMC: 9901533. DOI: 10.1590/1415-4757-GMB-2022-0158.

References

Szekeres-Bartho J, Barakonyi A, Par G, Polgar B, Palkovics T, Szereday L . Progesterone as an immunomodulatory molecule. Int Immunopharmacol. 2001; 1(6):1037-48. DOI: 10.1016/s1567-5769(01)00035-2. View

Piccinni M, Giudizi M, Biagiotti R, Beloni L, Giannarini L, Sampognaro S . Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol. 1995; 155(1):128-33. View

Gupta S, Kumar N, Singhal N, Manektala U, Jain S, Sodhani P . Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy. Diagn Cytopathol. 2006; 34(10):676-81. DOI: 10.1002/dc.20525. View

Baeten J, Nyange P, Richardson B, Lavreys L, Chohan B, Martin Jr H . Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol. 2001; 185(2):380-5. DOI: 10.1067/mob.2001.115862. View

Hel Z, Nacsa J, Kelsall B, Tsai W, Letvin N, Parks R . Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques. J Virol. 2001; 75(23):11483-95. PMC: 114735. DOI: 10.1128/JVI.75.23.11483-11495.2001. View

Prakash M, Kapembwa M, Gotch F, Patterson S . Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4(+) T cells in the cervical epithelium of healthy women. J Reprod Immunol. 2002; 54(1-2):117-31. DOI: 10.1016/s0165-0378(01)00125-5. View

Hanna L . The menstrual cycle and viral load. BETA. 2001; 12(2):18. View

Wira C, Fahey J, Sentman C, Pioli P, Shen L . Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev. 2005; 206:306-35. DOI: 10.1111/j.0105-2896.2005.00287.x. View

Sthoeger Z, Chiorazzi N, Lahita R . Regulation of the immune response by sex hormones. I. In vitro effects of estradiol and testosterone on pokeweed mitogen-induced human B cell differentiation. J Immunol. 1988; 141(1):91-8. View

10.

Brenchley J, Price D, Schacker T, Asher T, Silvestri G, Rao S . Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006; 12(12):1365-71. DOI: 10.1038/nm1511. View

11.

Mestecky J . Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites. J Reprod Immunol. 2007; 73(1):86-97. DOI: 10.1016/j.jri.2007.01.006. View

12.

Mestecky J, Moldoveanu Z, Elson C . Immune response versus mucosal tolerance to mucosally administered antigens. Vaccine. 2005; 23(15):1800-3. DOI: 10.1016/j.vaccine.2004.11.009. View

13.

Nardelli-Haefliger D, Wirthner D, Schiller J, Lowy D, Hildesheim A, Ponci F . Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst. 2003; 95(15):1128-37. DOI: 10.1093/jnci/djg018. View

14.

Paavonen T, Andersson L, Adlercreutz H . Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J Exp Med. 1981; 154(6):1935-45. PMC: 2186551. DOI: 10.1084/jem.154.6.1935. View

15.

Henin Y, Mandelbrot L, Henrion R, Pradinaud R, Coulaud J, Montagnier L . Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr (1988). 1993; 6(1):72-5. View

16.

Mati J, Hunter D, Maggwa B, Tukei P . Contraceptive use and the risk of HIV infection in Nairobi, Kenya. Int J Gynaecol Obstet. 1995; 48(1):61-7. DOI: 10.1016/0020-7292(94)02214-3. View

17.

Hladik F, Sakchalathorn P, Ballweber L, Lentz G, Fialkow M, Eschenbach D . Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity. 2007; 26(2):257-70. PMC: 1885958. DOI: 10.1016/j.immuni.2007.01.007. View

18.

Marx P, Spira A, Gettie A, Dailey P, Veazey R, Lackner A . Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med. 1996; 2(10):1084-9. DOI: 10.1038/nm1096-1084. View

19.

Pavia C, Siiteri P, Perlman J, Stites D . Suppression of murine allogeneic cell interactions by sex hormones. J Reprod Immunol. 1979; 1(1):33-8. DOI: 10.1016/0165-0378(79)90027-5. View

20.

Yovel G, Shakhar K, Ben-Eliyahu S . The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells. Gynecol Oncol. 2001; 81(2):254-62. DOI: 10.1006/gyno.2001.6153. View